A new Mass General research study suggests that physicians who take a more active role in connecting high-risk, longtime smokers with resources to help them quit can significantly improve their patients’ success at becoming smoke-free.
The study found that patients who receive annual lung cancer screenings due to high-risk smoking (averaging a pack a day for 30+ years) were 40% more likely to attempt quitting if their physicians provided them with direct assistance, such as connections to a treatment program, recommending or prescribing nicotine replacements or pharmaceutical aids, and then following up on those recommendations.
Of the group who agreed to try quitting, the chances of successful quitting increased by 46% with this active physician intervention. Elyse Park, PhD, of the Mass General Tobacco Treatment Center was lead author of the study.
A Mass General research study published earlier this year found—for the first time—evidence of neuroinflammation in the brain in patients with chronic pain. The study showed that levels of an inflammation- linked protein were elevated in regions of the brain known to be involved in the transmission of pain.
The discovery could make it possible to explore new treatments for chronic pain and
to find an objective way to measure the presence and/or intensity of chronic pain.
The inability to objectively measure chronic pain has been one of the most frustrating limitations on chronic pain treatment and research. Marco Loggia, PhD, of the Martinos Center for Biomedical Imaging is the lead author
of the study.
Did you know that the levels of estrogen or testosterone that you have in your body may play a role in how much you experience anxiety?
Dr. Mohammed Milad, director of the Behavioral Neuroscience Program at Mass General, has been studying how hormone levels in men and women can affect their feelings of anxiety–and the results are more surprising than you might think.
The main hope behind the network, put together by the Food Allergy Research & Education (FARE) organization, is to provide an estimated $2 million annually to up to 40 sites to host clinical trials on food allergy drugs.
Shamanic rituals that involve entering a trance state have been a part of the human experience for thousands of years. But we still know very little about the scientific basis of trances.
A team of investigators that included researchers from the Martinos Center for Biomedical Imaging at Mass General recently conducted MRI scans of 15 shamanic practitioners while they were in a trance state.
(Photo courtesy of Wikimedia Commons)
The results showed increased connectivity in parts of the brain involved in internally directed thought and cognitive control, as well as decreased connectivity in the auditory pathways in the brain.
This suggests that the repetitive drum sounds that are often used to induce trance states may help to focus the brain inward by creating a predictable rhythmic sound that is easy for practitioners to tune out. Michael Hove, PhD, of the Martinos Center, is both first and corresponding author of the study.
Mass General researchers are working on a deep brain stimulation device that may be able to help veterans returning from the battlefield with depression and post traumatic stress disorder (#PTSD) by stimulating key areas of the brain that may no longer be functioning correctly.
Neurosurgeon Dr. Emad Eskandar is working with a team of researchers to develop the matchbox-sized implant, which will provide electrical stimulation to various areas of the brain in response to unusual neuronal activity linked with depression and PTSD.
The project will utilize data collected by neurosurgeons and psychiatrists working at Mass General to help understand the relationship between nerve signaling and behavior.